April 15 (Reuters) - Intellipharmaceutics International Inc IPCI.TO :
* INTELLIPHARMACEUTICS INTERNATIONAL INC QTRLY LOSS PER SHARE $0.16
* INTELLIPHARMACEUTICS INTERNATIONAL - REVENUE OF $0.3 MILLION FOR 3 MONTHS ENDED FEB 28, 2019 VERSUS $0.3 MILLION FOR 3 MONTHS ENDED FEB 28, 2018
* INTELLIPHARMACEUTICS INTERNATIONAL INC - AS OF FEBRUARY 28, 2019, CASH BALANCE WAS $2.8 MILLION
* INTELLIPHARMACEUTICS INTERNATIONAL - EXPECT TO SATISFY OPERATING CASH REQUIREMENTS INTO Q3 2019 FROM CASH ON HAND & QTRLY PROFIT SHARE PAYMENTS
* INTELLIPHARMACEUTICS - ON APRIL 12,CO & MALLINCKRODT AGREED TO TERMINATE LICENSE & COMMERCIAL SUPPLY AGREEMENT EFFECTIVE NO LATER THAN AUGUST 31, 2019